Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license
Fierce Pharma
Moderna Therapeutics
vaccines
NIAID
COVID-19
Flag link:
The FDA has cleared the first home flu and Covid test — but its maker just declared bankruptcy
The FDA has cleared the first home flu and Covid test — but its maker just declared bankruptcy
Stat
FDA
COVID-19
Flu
diagnostics
Lucira
bankruptcy
Flag link:
Pfizer and BioNTech file BLA for Omicron-targeting Covid-19 vaccine
Pfizer and BioNTech file BLA for Omicron-targeting Covid-19 vaccine
Endpoints
Pfizer
BioNTech
COVID-19
Omicron
vaccines
FDA
Flag link:
Cerevel blames Covid for delayed neuroscience studies, says president is leaving
Cerevel blames Covid for delayed neuroscience studies, says president is leaving
Endpoints
Cerevel Therapeutics
COVID-19
epilepsy
Parkinson's Disease
darigabat
CVL-871
Flag link:
PhRMA official discusses legislative priorities, lessons from the pandemic
PhRMA official discusses legislative priorities, lessons from the pandemic
RAPS.org
PhRMA
legislation
pandemic
COVID-19
regulatory
Flag link:
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
Motley Fool
Pfizer
earnings
vaccines
COVID-19
Flag link:
'We beg you': Biotechs plead for help and funds to find long COVID treatments
'We beg you': Biotechs plead for help and funds to find long COVID treatments
Fierce Biotech
COVID-19
Long COVID
funding
biotech
Axcella Health
Flagship Pioneering
Flag link:
Merck’s COVID-19 treatment falls short in prevention study
Merck’s COVID-19 treatment falls short in prevention study
BioPharma Dive
Merck
COVID-19
Lagevrio
clinical trials
Flag link:
Where Will Moderna Be in 5 Years?
Where Will Moderna Be in 5 Years?
Motley Fool
Moderna Therapeutics
vaccines
MRNA
COVID-19
Flu
Flag link:
Labcorp forecasts up to 90% fall in COVID testing sales in 2023
Labcorp forecasts up to 90% fall in COVID testing sales in 2023
Yahoo/Reuters
LabCorp
diagnostics
COVID-19
Flag link:
Moderna promises to provide COVID vaccines at no out-of-pocket cost
Moderna promises to provide COVID vaccines at no out-of-pocket cost
Endpoints
Moderna Therapeutics
COVID-19
vaccines
boosters
Flag link:
GSK nixes next-gen COVID-19 antibody collaboration, leaving Vir to fly solo, seek new partners
GSK nixes next-gen COVID-19 antibody collaboration, leaving Vir to fly solo, seek new partners
Fierce Biotech
GSK
Vir Biotechnology
COVID-19
vaccines
Flag link:
Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China
Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China
BioSpace
Clover BioPharmaceuticals
China
COVID-19
vaccines
boosters
Flag link:
U.S. government to buy 1.5 mln more Novavax COVID vaccine doses
U.S. government to buy 1.5 mln more Novavax COVID vaccine doses
Yahoo/Reuters
Novavax
COVID-19
vaccines
federal government
Flag link:
Japan cancels 140M dose order for Novavax Covid vaccine amid 'lower than expected' demand
Japan cancels 140M dose order for Novavax Covid vaccine amid 'lower than expected' demand
Endpoints
Japan
Novavax
COVID-19
vaccines
Takeda
Flag link:
Lower COVID sales weigh on AZ in fourth quarter
Lower COVID sales weigh on AZ in fourth quarter
Pharmaphorum
AstraZeneca
COVID-19
vaccines
earnings
Flag link:
Preparing for next pandemic, Korea's SK pumps $261M into vaccine R&D site
Preparing for next pandemic, Korea's SK pumps $261M into vaccine R&D site
Fierce Biotech
SK Bioscience
COVID-19
vaccines
R&D
Flag link:
Merck pill linked to new mutations, study says
Merck pill linked to new mutations, study says
Fierce Pharma
Merck
antivirals
COVID-19
Lagevrio
Flag link:
FDA axes requirement for positive Covid test before Paxlovid use
FDA axes requirement for positive Covid test before Paxlovid use
Endpoints
FDA
Paxlovid
COVID-19
Flag link:
Gilead nixes Matinas oral COVID-19 antiviral to focus on late-phase internal program
Gilead nixes Matinas oral COVID-19 antiviral to focus on late-phase internal program
Fierce Biotech
Gilead Sciences
Matinas BioPharma
COVID-19
antivirals
Flag link:
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »